Key result
Intracoronary nifedipine improved contractile function recovery (17% vs -2%, p<0.01) and prevented ventricular fibrillation (0% vs 50%, p<0.01) in dogs with myocardial reperfusion injury.
Why the study?
Does intracoronary nifedipine improve sarcoplasmic reticulum function and contractile recovery in dogs undergoing myocardial ischemia and reperfusion?
RCT
randomized
Does intracoronary nifedipine improve sarcoplasmic reticulum function and contractile recovery in dogs undergoing myocardial ischemia and reperfusion?
Absolute Event Rate: 17% vs -2%
p-value: p=<0.01
In a canine model of ischemia-reperfusion, nifedipine prevented sarcoplasmic reticulum Ca2+ ATPase pump dysfunction and improved contractile recovery.
Hypothesis-generating for intracoronary nifedipine in reperfusion injury; leaves open translation to human practice pending trials.
OBJECTIVE: Sarcoplasmic reticulum dysfunction may contribute to calcium (Ca2+) overload during myocardial reperfusion. The aim of this study was to investigate its role in reperfusion injury. METHODS: Open chest dogs undergoing 15 min of left anterior descending coronary artery occlusion and 3 h of reperfusion were randomized to intracoronary infusions of 0.9% saline, vehicle, or the Ca2+ channel antagonist, nifedipine (50 micrograms/min from 2 minutes before to 5 minutes after reperfusion). After each experiment, transmural myocardial biopsies were removed from ischemic/reperfused and nonischemic myocardium in the beating state and analyzed for (i) sarcoplasmic reticulum protein content (Ca2+ ATPase, phospholamban, and calsequestrin) by immunoblotting and (ii) Ca2+ uptake by sarcoplasmic reticulum vesicles with and without 300 micromolar ryanodine or the Ca2+ ATPase activator, antiphospholamban (2D12) antibody. RESULTS: Contractile function did not recover in controls and vehicle-treated dogs after ischemia and reperfusion (mean systolic shortening, -2 +/- 2%), but completely recovered in nifedipine-treated dogs (17 +/- 2%, p = NS vs. baseline, p < 0.01 vs. control). Ventricular fibrillation occurred in 50% of controls and vehicle dogs and 0% of nifedipine-treated dogs (p < 0.01). Ca2+ uptake by the sarcoplasmic reticulum vesicles was severely reduced in ischemic/reperfused myocardium of controls and vehicle dogs (p < 0.01 vs. nonischemic). Ryanodine and the 2D12 antibody improved, but did not reverse the low Ca2+ uptake. Protein content was similar in ischemic/reperfused and nonischemic myocardium. In contrast, Ca2+ uptake and the responses to ryanodine and 2D12 antibody were normal in ischemic/reperfused myocardium from nifedipine-treated dogs. CONCLUSION: Dysfunction of the sarcoplasmic reticulum Ca2+ ATPase pump correlates with reperfusion injury. Reactivation of Ca2+ channels at reperfusion contributed to Ca2+ pump dysfunction. Ca2+ pump injury may be a critical event in myocardial reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Smart et al. (1997) conducted an RCT in Myocardial reperfusion injury. Nifedipine vs. 0.9% saline or vehicle was evaluated on Mean systolic shortening (p=<0.01). Intracoronary nifedipine improved contractile function recovery (17% vs -2%, p<0.01) and prevented ventricular fibrillation (0% vs 50%, p<0.01) in dogs with myocardial reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: